Yingzi Yang | Biological Networks | Research Excellence Award

Published on by Network Science

Prof. Yingzi Yang | Biological Networks | Research Excellence Award

Harvard School of Dental Medicine | United States

Prof. Yingzi Yang is a distinguished developmental biologist whose career spans leading institutions including Harvard Medical School and the National Institutes of Health. She earned her BS in Biology from Fudan University in 1988 and completed her PhD in Molecular Biology at the Sloan-Kettering Institute and Weill Medical College of Cornell University in 1996, followed by postdoctoral training with Andrew P. McMahon at Harvard University. She joined the NIH in 2000 as an Investigator and rose to Senior Investigator before being appointed Professor of Developmental Biology at Harvard Medical School in 2015, where she also serves as Principal Faculty of the Harvard Stem Cell Institute and a member of the Dana-Farber/Harvard Cancer Center. Widely recognized for her contributions to Wnt signaling, skeletal biology, and developmental mechanisms, Prof. Yang has received numerous honors including the AAAS Fellowship, ASBMR Fellowship, the IADR Distinguished Scientist Award, multiple NIH Awards of Merit, and the Vincent du Vigneaud Award of Excellence. She has held major leadership roles such as President of the Chinese Biological Investigators Society (2022–2024), member of the NIH SBDD Study Section, and keynote speaker at national scientific meetings. Her extensive service includes high-level Harvard committees, NIH central tenure committees, Gordon Research Conference leadership, international symposium organization, and major grant review panels for NIH, NSF, and global scientific agencies. A respected scholar and reviewer for top-tier journals including Cell, Nature family journals, Science family journals, and Development, Prof. Yang is recognized worldwide for advancing fundamental understanding of developmental and stem cell biology and their implications for human disease.

Profiles: Scopus | Google Scholar

Featured Publications

"Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation", Y Liu, J Zhu, Y Jin, Z Sun, X Wu, H Zhou, Y Yang, Nature Communications 16 (1), 2025.

"Fibrous dysplasia/McCune-Albright syndrome: state-of-the-art advances, pathogenesis, and basic/translational research", B Palmisano, C Berry, A Boyce, JF Charles, MT Collins, A Corsi, FA Fierro, Orphanet Journal of Rare Diseases 20 (1), 2025.

"Piezo1-mediated mechanotransduction controls osteocyte maturation and dendrite development via a YAP-CCN-Src signaling axis", YJ Hu, X Wu, F Wang, Y Jin, Y Jin, Y Liu, Q Cong, Y Yang, Nature Communications, 2025.

"Injury-induced niche factors Cxcl12 and Shh/Ihh coordinate suture stem cell activation during calvarial bone regeneration", B Li, T Ouchi, J Liu, Y Yang, Science Signaling 18 (909), 2025.

"Neutralization of Receptor activator of nuclear factor-κB ligand reduces fibrosis and promotes osteoblast differentiation in a mouse model of fibrous dysplasia driven", RT Ormsby, Y Zhang, C Hodys, LA Wake, SM Perez, K Tsang, Y Yang, JBMR plus 9 (10), 2025.

Marco Cirillo | Interactive Analytics | Best Researcher Award

Published on by Network Science

Dr. Marco Cirillo | Interactive Analytics | Best Researcher Award

Non-Profit Polyambulance Foundation | Italy

Dr. Marco Cirillo is a distinguished cardiac surgeon whose career seamlessly bridges clinical excellence and experimental research. After completing classical studies, he graduated in Medicine and Surgery with highest honors  from the University of Bologna and specialized in Cardiac and Great Vessels Surgery. His career has encompassed leadership roles as Head of the Cardiac Surgery Unit in Bologna for six years and the Heart Failure Surgery Unit in Brescia for twelve years. With expertise spanning the full range of traditional cardiac surgery-including mitral repair, coronary bypass, valve replacement, and aortic arch procedures-Dr. Cirillo has performed over 8,000 surgeries as first surgeon. His innovative contributions include the KISS procedure for physiological left ventricular reconstruction, the “Arterial-source No-touch Aorta” technique for off-pump coronary revascularization, and the NINFEA method for annular stabilization in endocarditis. Renowned for his commitment to quality and risk management (JCI accreditation), he continues to advance the field through research on bioprostheses and ventricular assist systems, recognized internationally through publications and awards. In 2025, he earned a Master’s degree in Echocardiography from the University of Verona. Beyond medicine, his intellectual pursuits extend to writing, photography, and cosmology, where he recently published a paper exploring Darwinian natural evolution as applied to the development of the Universe.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Achilles and the Tortoise: Rethinking Evidence Generation in Cardiovascular Surgery and Interventional Cardiology", Marco Cirillo, Hearts, 2025.

"Abiotrophia defectiva and Granulicatella: A Literature Review on Prosthetic Joint Infection and a Case Report on defectiva PJI and Concurrent Native Valve Endocarditis", MCristina Seguiti; Edda Piacentini; Angelica Fraghì; Mattia Zappa; Elia Croce; Angelo Meloni; Marco Cirillo; Clarissa Ferrari; Chiara Zani; David Belli et al., Microorganisms, 2025.

"Finger ischemia in a young lady: an unusual presentation of papillary fibroelastoma with intraventricular location", Matteo Pernigo; Elisabetta Dinatolo; Marco Cirillo; Zean Mhagna; Alida Filippini; Fabiana Cozza; Marco Berti; Roberto Bazzani; Tony Sabatini; Claudio Cuccia et al., Monaldi Archives for Chest Disease, 2023.

"Exploring Personal Protection During High-Risk PCI in a COVID-19 Patient", Marco Cirillo, JACC: Case Reports, 2020.

María Eugenia Marín Martínez | Biological Network | Women Researcher Award

Published on by Network Science

Dr. María Eugenia Marín Martínez | Biological Network | Women Researcher Award

Infanta Cristina University Hospital | Spain

Dr. María Eugenia Marín Martínez is a distinguished specialist in Obstetrics and Gynecology with a Bachelor’s degree in Medicine from the University of Valladolid and extensive experience across leading hospitals in Madrid, including Puerta de Hierro Majadahonda University Hospital and Infanta Cristina University Hospital. Dedicated to advancing women’s health at every stage of life, she has been deeply involved in the prevention, diagnosis, and treatment of gynecological conditions. Her professional journey reflects a strong commitment to excellence, having contributed to the development of clinical protocols, particularly during the COVID-19 pandemic, and spearheaded pioneering work in the field of uterine fibroid management through radiofrequency ablation-performing over 200 procedures and establishing her center as a national and international reference. Dr. Marín is pursuing her doctoral thesis on radiofrequency ablation at the Autonomous University of Madrid, with expected defense in 2026. She actively participates in multidisciplinary committees on breastfeeding, gender violence, and chronic pelvic pain, and contributes to humanitarian medical missions in Cameroon. A dedicated educator and researcher, she has authored multiple peer-reviewed publications, book chapters, and clinical guides, while also directing international training courses in gynecological radiofrequency treatment. Through her leadership, innovation, and compassionate care, Dr. Marín continues to play a vital role in advancing obstetric safety, women’s health, and medical education in Spain and beyond.

Profiles: Scopus

Featured Publications

"Transvaginal radiofrequency ablation: a therapeutic option for managing symptomatic uterine fibroids in women with reproductive desires",Maria Eugenia Marin Martinez, F and S Reports, 2024.

Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Reliance Life Sciences Pvt Ltd | India

Dr. Nikhil Sudhir Sathe (PhD), currently associated with Laboratory Animal Research Services (LARS), is a distinguished researcher with over 20 years of expertise in drug discovery and preclinical evaluation of new chemical entities. His extensive professional experience encompasses in vitro genotoxicology, cell and microbial culture (aerobic, anaerobic, and viral systems including rabies virus), and small laboratory animal studies. Throughout his career at Reliance Life Sciences, Vimta Labs, Dabur Research Centre, and Wockhardt Research Centre, Dr. Sathe has demonstrated exceptional proficiency in GLP-compliant laboratory practices, including bacterial reverse mutation, chromosomal aberration, micronucleus, ELISA, cytotoxicity, and microbial monitoring assays. His early research contributions involved innovative in vitro models for evaluating the efficacy of antimicrobial and cosmetic products. Academically, he holds a Master’s and Bachelor’s degree in Microbiology from Shivaji University, Kolhapur, both with distinction. Dr. Sathe has contributed significantly to scientific literature with publications in reputed journals such as Vaccine, Microbial Pathogenesis, Infectious Medicine, and BioMed, focusing on bacteriophage therapy and vaccine development against multidrug-resistant pathogens and SARS-CoV-2. His scholarly achievements are complemented by active participation in national conferences and workshops, reflecting his deep commitment to advancing microbiological and biomedical research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Unveiling Lytic Bacteriophages as Promising Biotherapeutics for the Control of Multidrug-Resistant Pseudomonas aeruginosa", CS Nikhil Sathe, Eugene Athan, Arnab Kapat, BioMed, 2025.

"Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus", N Sathe, S Shaikh, M Bhavsar, L Parte, A Gadiparthi, S Kad, S Sensarma, Vaccine, 2024.

"Bacteriophage vB_kpnS-Kpn15: Unveiling its potential triumph against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae-Unraveling efficacy through innovative", N Sathe, C Suphioglu, E Athan, A Kapat, Microbial Pathogenesis, 2024.

"Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment", N Sathe, P Beech, L Croft, C Suphioglu, A Kapat, E Athan, Infectious medicine 2, 2023.

"Development of a novel therapy using bacteriophages: An alternative to antibiotics", NS Sathe, Deakin University, 2023.

Tamar Kinaciyan | Medicine | Best Research Article Award

Published on by Network Science

Dr. Tamar Kinaciyan | Medicine | Best Research Article Award

Department of Dermatotolgy, Medical University of Vienna | Austria

Author Profile

Scopus

Orcid ID

Early Academic Pursuits

Dr. Tamar Kinaciyan embarked on her medical and dermatological journey at the Medical University of Vienna, where she completed her dermatology board examination in 1996 and specialized in environmental medicine and clinical allergology. Her early academic roles included heading the Borrelia-Outpatient Clinic (1994–2000) and directing immune fluorescence microscopy and antigen-mapping laboratories for bullous and connective tissue diseases (1993–1998). She further strengthened her clinical research foundation through diplomas in dermatoscopy, clinical investigation, and lung function analysis, laying a solid groundwork for her career in pediatric dermatology and allergology.

Professional Endeavors

Dr. Kinaciyan’s professional trajectory spans nearly three decades, marked by leadership roles in both clinical and organizational settings. She serves as Head of the Allergy and Pediatric Dermatology Clinics at the Department of Dermatology, Medical University of Vienna, and leads multiple specialized centers, including ACARE, HAE, and UCARE. Her contributions extend to international collaboration through Ga2LEN ACARE Centers and to advocacy for women in science as founder and honorary president of the Women’s Science Network Medicine. She has also held numerous key roles in Austrian and European scientific societies, reflecting her commitment to both clinical excellence and professional mentorship.

Contributions and Research Focus

Dr. Kinaciyan’s research primarily focuses on hereditary angioedema, urticaria, mastocytosis, and pediatric dermatology, alongside investigations into food allergies, latex allergy, drug hypersensitivity, and eczema. She has led and participated in multiple clinical trials, EU projects, and Austrian national studies, including the Austrian Registry of Bradykinin-mediated Angioedema and studies on sublingual immunotherapy for birch pollen-related food allergies. Her work bridges clinical and translational research, advancing diagnostic and therapeutic approaches for rare and complex allergic and dermatologic conditions.

Impact and Influence

Her clinical and research expertise has significantly influenced European and global dermatology and allergology communities. Dr. Kinaciyan has chaired numerous congress sessions, contributed to guideline task forces, and served as an editorial board member for several high-impact journals, including the Journal of Exploration of Asthma & Allergy. Her mentorship and advocacy efforts, particularly through WNW-med, have empowered foreign-trained physicians and supported gender equity in medical sciences, establishing her as both a thought leader and a mentor.

Academic Citations

Dr. Kinaciyan has a strong publication record with 88 peer-reviewed, Medline-indexed articles, totaling an impact factor of 782.704 and an h-index of 28. Her contributions span original research, invited articles, book chapters, and case studies in prestigious journals and texts, reflecting her broad influence across allergology and dermatology.

Legacy and Future Contributions

Dr. Kinaciyan’s legacy lies in her dual commitment to advancing clinical dermatology and fostering the next generation of medical researchers. By integrating cutting-edge research with patient-centered care and promoting inclusive academic networks, she has set a standard for excellence in both practice and mentorship. Moving forward, her continued focus on hereditary angioedema, pediatric dermatology, and clinical allergology promises to deepen scientific understanding and improve patient outcomes globally.

Conclusion

Dr. Tamar Kinaciyan exemplifies a rare combination of clinical acumen, research innovation, and leadership. Her pioneering work in hereditary angioedema and pediatric dermatology, coupled with her dedication to professional development and mentorship, has left an indelible mark on the field. With a prolific publication record, numerous awards, and sustained international impact, she stands as a leading figure whose ongoing contributions continue to advance both science and patient care.

Notable Publications

“Diagnostic difficulties in pediatric annular dermatoses" 

  • Author: Doris Weiss; Philipp Weber; Amélie Hampel; Julia Tittes; Wolfgang Weninger; Tamar Kinaciyan
  • Journal: Wiener Medizinische Wochenschrift
  • Year: 2024

“The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation" 

  • Author: Buttgereit T; Aulenbacher F; Gutsche A; Kolkhir P; Weller K; Vera Ayala C; Magerl M; Farkas H; Grumach AS; Aygören-Pürsün E et al.
  • Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • Year: 2024

“Docetaxel‐induced symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing" 

  • Author: Amélie Hampel; Tamar Kinaciyan
  • Journal: Contact Dermatitis
  • Year: 2024

“Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus" 

  • Author: Reshef A; Buttgereit T; Betschel SD; Caballero T; Farkas H; Grumach AS; Hide M; Jindal AK; Longhurst H; Peter J et al.
  • Journal: The Journal of allergy and clinical immunology
  • Year: 2024

“The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case." 

  • Author: Riebenbauer K; Czerny S; Egg M; Urban N; Kinaciyan T; Hampel A; Fidelsberger L; Karlhofer F; Porkert S; Walochnik J et al.
  • Journal: PLoS neglected tropical diseases
  • Year: 2024

 

 

 

Orhan Özturan | Research | Best Researcher Award

Published on by Network Science

Prof Orhan Özturan | Research | Best Researcher Award

Bezmialem Vakif University | Turkey

Author Profiles

Scopus

Google Scholar

Early Academic Pursuits

Dr. Orhan Özturan, born in Gaziantep in 1961, displayed academic excellence from an early stage. After graduating from Private Adana College in 1978, he pursued medical education at Hacettepe University, later transferring to Erciyes University, Faculty of Medicine, where he graduated as the second-highest-ranked student. His strong foundation in medicine set the stage for his specialization and subsequent contributions to the field of otorhinolaryngology.

Professional Endeavors

Following his compulsory service in Sivas (1984–1986), Dr. Özturan specialized in Ear, Nose, and Throat (ENT) diseases at Istanbul University. His career trajectory advanced steadily, beginning as an ENT specialist at Adana SSK Hospital (1991–1993) and later transitioning to academia. His academic journey started at İnönü University, where he rose through the ranks from Assistant Professor (1993) to Associate Professor (1995) and Professor (2001). His leadership extended into key administrative positions, including department head roles and hospital executive responsibilities, reflecting both clinical and managerial expertise.

Contributions and Research Focus

Dr. Özturan’s research and clinical work span a wide range of ENT subspecialties, with particular emphasis on nasal congestion, sinusitis, functional and aesthetic nose surgeries, sleep apnea management, pediatric ENT conditions, hearing loss, cochlear implantation, vertigo, and laryngeal cancer. His professional interests also encompass advanced surgical interventions, including eardrum reconstruction, facial nerve surgeries, and salivary gland treatments. His global training in Australia, the USA, and Israel enhanced his expertise and broadened his research outlook.

Impact and Influence

As an internationally recognized figure, Dr. Özturan has contributed substantially to advancing otorhinolaryngology. With 251 publications in international journals and 79 in national outlets, his work reflects both breadth and depth. His active participation in 64 international and 224 national meetings demonstrates his role as a thought leader and mentor within the medical community. His administrative service-as Vice Rector, Ethics Committee Vice Chair, and Chair of the Academic Performance Monitoring Commission-illustrates his influence beyond the clinic, shaping institutional policies and academic growth.

Academic Citations

The academic impact of Dr. Özturan’s scholarship is demonstrated by his impressive citation metrics. As of August 8, 2025, his Google Scholar citation count stands at 5,066, with an h-index of 39 and an i10-index of 126. These figures not only reflect the consistent quality of his research but also his enduring influence in shaping scientific inquiry within ENT and allied fields.

Legacy and Future Contributions

Dr. Özturan’s legacy is defined by his dual commitment to clinical excellence and academic advancement. His pioneering work in nasal surgery, cochlear implants, and sleep apnea treatment has provided new pathways for therapeutic intervention. As a mentor and leader, he has guided students, researchers, and practitioners, ensuring the continuity of high standards in medical education and practice. Looking ahead, his ongoing involvement at Bezmialem Vakif University positions him to continue shaping ENT research and medical education, inspiring future generations of otorhinolaryngologists.

Conclusion

In sum, Dr. Orhan Özturan’s career reflects a rare combination of clinical expertise, research productivity, and academic leadership. His early academic brilliance matured into a distinguished professional life marked by innovation, international collaboration, and scholarly impact. With a strong legacy already established, his future contributions are poised to further strengthen the global discourse in otorhinolaryngology, making him a worthy candidate for recognition as a leading researcher in his field.

Notable Publications

“Effect of Medical Ozone Therapy in Preventing Compromised Nasal Skin in Revision Rhinoplasty" 

  • Author: A Alp, E Polat, A Yenigun, O Pasin, O Ozturan
  • Journal: Aesthetic Plastic Surgery
  • Year: 2025

“Radiologic prevalence of otic capsule dehiscence and development of the Yenigun classification for semicircular canal dehiscence" 

  • Author: A Yenigun, YB Polat, E Polat, S Balsak, M Basoz, SB Eren, O Ozturan
  • Journal: Auris Nasus Larynx
  • Year: 2025

“Intranasal Diclofenac Sodium, Ibuprofen and Paracetamol for Pain Relief After Pediatric Tonsillectomy" 

  • Author: A Yenigün, RB Küçük, MF Özgan, H Uysal, AA Sağıroğlu, VB YENİGÜN
  • Journal: International Journal of Pediatric Otorhinolaryngology
  • Year: 2025

“Enhancing Nasal Tip Projection and Stability with a Columellar Strut Graft Placed in a Mucosal Flap Pocket" 

  • Author: M Ceran, A Yenigun, E Polat, O Ozturan
  • Journal: JPRAS Open
  • Year: 2025

“Spectral resolution and speech comprehension performance in noise in individuals with multiple sclerosis" 

  • Author: ÖG Toker, E Kuru, N Tas Elibol, V Güzel, R Doğan, O Özturan
  • Journal: BMC neurology
  • Year: 2025

 

 

June Round | Biological Networks | Best Researcher Award 

Published on by Network Science

Dr. June Round | Biological Networks | Best Researcher Award 

University of Utah | United States

Author Profiles

Scopus

Google Scholar

Early Academic Pursuits

Dr. June Round’s academic journey reflects a foundation of dedication and scholarly excellence. Beginning with a B.S. in Biology (Cum Laude) at California Lutheran University, she distinguished herself early through departmental honors and multiple scholarships. Her passion for molecular biology led to an M.S. from the University of the Pacific, followed by a D.Phil. in Microbiology, Immunology, and Molecular Genetics at UCLA, supported by highly competitive fellowships. Her formative postdoctoral training at the California Institute of Technology under Sarkis K. Mazmanian provided a strong platform to explore the intricate interplay between microbiota and host immunity, setting the stage for her pioneering career.

Professional Endeavors

Currently serving as a Professor at the University of Utah, Dr. Round has held numerous leadership roles including Director of the Mountain West Microbiota Alliance (MoWMA) and Co-Director of the Microbiota and GI Immunology Consortia (MAGIC). She has chaired multiple search committees, overseen postdoctoral studies, and contributed extensively to university-level, college-level, and departmental governance. Her sustained involvement in NIH study sections, national symposia, and scientific advisory boards underscores her standing as a leader in immunology and microbial pathogenesis.

Contributions and Research Focus

Dr. Round’s research focuses on microbiota–immune system interactions, particularly their role in regulating immune tolerance and driving inflammatory diseases. Her laboratory has produced high-impact work elucidating mechanisms by which commensal microbes shape host immunity, contributing to transformative understanding in immunology, microbiology, and gastrointestinal health. Her investigations into toll-like receptors, dysbiosis, and immune regulation have provided new frameworks for therapeutic exploration in autoimmune and inflammatory disorders.

Impact and Influence

The significance of Dr. Round’s research is reflected in her numerous prestigious awards, including the NIH Innovator Award, Packard Fellowship, Pew Scholar Award, Burroughs Wellcome Investigator in Pathogenesis, and the W.M. Keck Research Award. These honors not only recognize her innovative contributions but also demonstrate her influence in shaping the field. She has trained and mentored a generation of young scientists, many of whom now serve as professors, researchers, and clinicians in leading institutions worldwide—an enduring testament to her academic leadership.

Academic Citations and Recognition

Dr. Round’s scholarship has been widely published in top-tier journals including Cell, Nature Reviews Immunology, Science Immunology, and Annual Review of Microbiology. Her reviews and original research articles are highly cited, frequently shaping discourse in immunology and microbiome research. Her contributions extend beyond publications through book chapters and invited conference proceedings, amplifying her thought leadership in the global scientific community.

Legacy and Future Contributions

Dr. Round’s legacy lies in bridging microbiology and immunology, redefining the microbiota’s role in human health and disease. Through her pioneering studies, administrative leadership, and mentorship, she has cultivated a scientific ecosystem that will continue to grow. Moving forward, her leadership in major microbiome initiatives and consortia is poised to advance translational breakthroughs, from novel therapeutics for autoimmune disease to deeper insights into the human–microbe interface.

Conclusion

Dr. June Round’s career reflects the hallmarks of an exceptional researcher: rigorous scholarship, innovative vision, academic leadership, and transformative mentorship. Her pioneering contributions to microbiome and immune system research have reshaped fundamental scientific understanding while fostering future leaders in biomedical science. With her remarkable impact, both in the laboratory and across academic institutions, Dr. Round stands as an exemplary candidate for the Best Researcher Award.

Notable Publications

"Neonatal fungi promote lifelong metabolic health through macrophage-dependent β cell development" 

  • Author: JH Hill, R Bell, L Barrios, H Baird, K Ost, M Greenewood, JK Monts
  • Journal: Science
  • Year: 2025

"The gut microbiome is associated with disease‐free survival in stage I–III colorectal cancer patients" 

  • Author: DA Byrd, V Damerell, MF Gomez Morales, SR Hogue, T Lin, J Ose
  • Journal: International Journal of Cancer
  • Year: 2025

"A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy" 

  • Author: WW Tang, B Battistone, KM Bauer, AM Weis, C Barba, MZH Fadlullah
  • Journal: Cell reports
  • Year: 2025

"Primary tumor microbiomes predict distant metastasis of colorectal cancer" 

  • Author: B Parajuli, V Midya, R Kiddle, N De Jager, S Eggers, D Spakowicz
  • Journal: Cell reports
  • Year: 2025

"Clec12a controls colitis by tempering inflammation and restricting expansion of specific commensals" 

  • Author: TR Chiaro, M Greenewood, KM Bauer, KS Ost, E Stephen-Victor
  • Journal: bioRxiv
  • Year: 2025